Tech Company Financing Transactions
GlycoGenesys Funding Round
On 3/9/2006, GlycoGenesys landed $6.5 million in Series D financing from .
Transaction Overview
Company Name
Announced On
3/9/2006
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Series D
Investors
No investors have been recorded for this company.
Proceeds Purpose
The financing will be used primarily for funding the costs of enrolling and conducting clinical trials for GCS-100LE as a treatment for various cancers, according to GlycoGenesys.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
31 St. James Avenue 8th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Not Recorded
Overview
GlycoGenesys, Inc. is a biotechnology company developing novel drug candidates primarily based on glycobiology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradley Carver
Browse more venture capital transactions:
Prev: 3/8/2006: Atritech venture capital transaction
Next: 3/9/2006: Ahura Scientific venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs